We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine (SASL28)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01005238
Recruitment Status : Terminated (unsufficient patient recruitment)
First Posted : October 30, 2009
Last Update Posted : March 10, 2015
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : December 2014
  Study Completion Date : No date given